2
Clinical Trials associated with KEM-2102KEM2102在中国健康志愿者中单次/多次给药的药代动力学研究及安全性、耐受性研究
[Translation] Pharmacokinetics, safety and tolerability of KEM2102 after single/multiple administration in Chinese healthy volunteers
单次给药:
主要目的:评估和对比KEM2102与对照药双氯芬酸二乙胺乳胶剂、双氯芬酸依泊胺贴在中国健康受试者中单次给药药代动力学(PK)特征;
次要目的:评估和对比KEM2102与对照药双氯芬酸二乙胺乳胶剂、双氯芬酸依泊胺贴在中国健康受试者中单次给药的黏附性、皮肤刺激性以及安全性和耐受性。
多次给药:
主要目的:评估和对比KEM2102与对照药双氯芬酸二乙胺乳胶剂在中国健康受试者中多次给药药代动力学(PK)特征;
次要目的:评估和对比KEM2102与对照药双氯芬酸二乙胺乳胶剂在中国健康受试者中多次给药的黏附性、皮肤刺激性以及安全性和耐受性。
[Translation] Single administration:
Primary purpose: To evaluate and compare the pharmacokinetic (PK) characteristics of KEM2102 and the control drugs diclofenac diethylamine emulsion and diclofenac epolamide patch after single administration in Chinese healthy subjects;
Secondary purpose: To evaluate and compare the adhesion, skin irritation, safety and tolerability of KEM2102 and the control drugs diclofenac diethylamine emulsion and diclofenac epolamide patch after single administration in Chinese healthy subjects.
Multiple administration:
Primary purpose: To evaluate and compare the pharmacokinetic (PK) characteristics of KEM2102 and the control drug diclofenac diethylamine emulsion after multiple administration in Chinese healthy subjects;
Secondary purpose: To evaluate and compare the adhesion, skin irritation, safety and tolerability of KEM2102 and the control drug diclofenac diethylamine emulsion after multiple administration in Chinese healthy subjects.
KEM2102在中国健康志愿者中单次/多次给药的药代动力学研究及安全性、耐受性研究
[Translation] Pharmacokinetics, safety and tolerability of KEM2102 after single/multiple administration in Chinese healthy volunteers
主要目的:评估和对比KEM2102与对照药双氯芬酸二乙胺乳胶剂在中国健康受试者中单次及多次给药药代动力学(PK)特征。
次要目的:评估和对比KEM2102与对照药双氯芬酸二乙胺乳胶剂在中国健康受试者中单次/多次给药的黏附性、皮肤刺激性以及安全性和耐受性。
[Translation] Primary objective: To evaluate and compare the pharmacokinetic (PK) characteristics of KEM2102 and the control drug diclofenac diethylamine emulsion after single and repeated administration in healthy Chinese subjects.
Secondary objective: To evaluate and compare the adhesion, skin irritation, safety and tolerability of KEM2102 and the control drug diclofenac diethylamine emulsion after single/multiple administration in healthy Chinese subjects.
100 Clinical Results associated with KEM-2102
100 Translational Medicine associated with KEM-2102
100 Patents (Medical) associated with KEM-2102
100 Deals associated with KEM-2102